CHINA PHARMA HOLDINGS, INC.(CPHI)— Stock Profile, AI Score & Financials
Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
CHINA PHARMA HOLDINGS, INC. (CPHI) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CPHI is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 8 institutional filers currently hold this stock. Based on the latest XBRL financial filings (Q2 2026), CHINA PHARMA HOLDINGS, INC. reports quarterly revenue of $948.3K, net income of $-1.5M. Top institutional holders of CPHI by reported 13-F value include CITADEL ADVISORS, TWO SIGMA SECURITIES, RENAISSANCE TECHNOLOGIES, based on the most recent SEC filings. CPHI trades on the NYSE exchange and files with the SEC under CIK 1106644. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CPHI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CHINA PHARMA HOLDINGS, INC. directly from SEC EDGAR.
Revenue
$948.3K
Net Income
$-1.5M
CPHI key financials by period
CHINA PHARMA HOLDINGS, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$4.1M
$-3.2M
-78.2%
FY 2024
10-K
$4.5M
$-4.7M
-101.3%
FY 2023
10-K
$7.0M
$-3.1M
-39.3%
FY 2022
10-K
$8.1M
$-4.0M
-43.8%
FY 2021
10-K
$9.6M
$-3.4M
-29.7%
FY 2020
10-K
$10.9M
$-2.9M
-23.7%
Institutions holding CPHI
Institutional investors reporting a position in CHINA PHARMA HOLDINGS, INC. on SEC Form 13F.
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 8 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Price Chart
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
